![Enrique Carrazana](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Enrique Carrazana
Direttore/Membro del Consiglio presso Hawaii Biotech, Inc.
Posizioni attive di Enrique Carrazana
Società | Posizione | Inizio | Fine |
---|---|---|---|
Hawaii Biotech, Inc.
![]() Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | Direttore/Membro del Consiglio | - | - |
Neurelis, Inc.
![]() Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 15/05/2023 | - |
Direttore Tecnico/Scientifico/R&S | 01/04/2020 | 15/05/2023 | |
Cnd Life Sciences, Inc.
![]() Cnd Life Sciences, Inc. Medical/Nursing ServicesHealth Services Cnd Life Sciences, Inc. is a company based in an undisclosed location that aims to transform the diagnosis and treatment of neurodegenerative diseases. The company is based in Scottsdale, AZ. The company operates a CLIA-certified and CAP-accredited laboratory and has launched the Syn-One test, the world's first commercially available test that detects and visualizes phosphorylated alpha-synuclein in cutaneous nerves with high accuracy to aid the diagnosis of Parkinson's disease and related disorders. Cnd Life Sciences has scientific collaborations with biopharmaceutical companies and has been awarded three NIH SBIR grants to advance the clinical utility of the Syn-One test. The company allows clinicians to access objective pathological insights on diseases that are often difficult to diagnose and apply those insights to generate better outcomes for patients. The company was founded in 2017 by Todd Dylan Levine, Christopher Gibbons, Roy Freeman, and the CEO is Richard J. Morello. | Direttore/Membro del Consiglio | 07/09/2021 | - |
Storia della carriera di Enrique Carrazana
Precedenti posizioni note di Enrique Carrazana
Società | Posizione | Inizio | Fine |
---|---|---|---|
MARINUS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/11/2013 | 30/06/2021 |
Independent Dir/Board Member | 01/11/2013 | 30/06/2021 | |
ACORDA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 15/10/2011 | 04/01/2016 |
The University of Miami Leonard M. Miller School of Medicine | Corporate Officer/Principal | 01/10/2010 | 01/09/2011 |
NOVARTIS AG | Corporate Officer/Principal | 01/01/2001 | 01/01/2010 |
Miami VA Health Care System / Research | Corporate Officer/Principal | - | - |
Formazione di Enrique Carrazana
Harvard Medical School | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 9 |
Svizzera | 2 |
Posizioni
Corporate Officer/Principal | 4 |
Director/Board Member | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Settori
Health Technology | 6 |
Consumer Services | 3 |
Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
ACORDA THERAPEUTICS, INC. | Health Technology |
MARINUS PHARMACEUTICALS, INC. | Health Technology |
NOVARTIS AG | Health Technology |
Aziende private | 4 |
---|---|
Miami VA Health Care System / Research | |
Hawaii Biotech, Inc.
![]() Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | Health Technology |
Neurelis, Inc.
![]() Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | Health Technology |
Cnd Life Sciences, Inc.
![]() Cnd Life Sciences, Inc. Medical/Nursing ServicesHealth Services Cnd Life Sciences, Inc. is a company based in an undisclosed location that aims to transform the diagnosis and treatment of neurodegenerative diseases. The company is based in Scottsdale, AZ. The company operates a CLIA-certified and CAP-accredited laboratory and has launched the Syn-One test, the world's first commercially available test that detects and visualizes phosphorylated alpha-synuclein in cutaneous nerves with high accuracy to aid the diagnosis of Parkinson's disease and related disorders. Cnd Life Sciences has scientific collaborations with biopharmaceutical companies and has been awarded three NIH SBIR grants to advance the clinical utility of the Syn-One test. The company allows clinicians to access objective pathological insights on diseases that are often difficult to diagnose and apply those insights to generate better outcomes for patients. The company was founded in 2017 by Todd Dylan Levine, Christopher Gibbons, Roy Freeman, and the CEO is Richard J. Morello. | Health Services |
- Borsa valori
- Insiders
- Enrique Carrazana
- Esperienza